HearingAssist Control vs Signia Pure C&G IX

The HearingAssist Control is a behind-the-ear OTC hearing aid priced at $549, earning a B grade with a SoundScore of 3.3/5 in our lab testing. This places it in the lower portion of the OTC category, ranking #51 of 65 devices tested. In our testing, the Control demonstrates notable strengths in speech performance. Speech in quiet scores 0.59 points above the category average at 3.4/5, representing solid absolute performance. Speech in noise comes in at 2.0/5—above the category average by 0.56 points, though only mixed in absolute terms. Feedback handling is excellent at 5.0/5, meaning the device remained stable without audible squealing during our standardized challenge tests. The device shows significant weaknesses in other areas. Music streaming scored 0.0/5, which is 1.92 points below the category average and indicates this device does not support or perform well with phone audio streaming. Own-voice comfort is also below average at 2.1/5 (0.41 points below category average), which may be noticeable during extended conversations. The HearingAssist Control may suit users who prioritize speech clarity over streaming functionality and who don't require premium sound quality across all use cases. However, buyers in this price range should note that several competitors—including the Yeasound RIC800 and Sony CRE-E10—deliver substantially higher overall scores. Those seeking similar speech performance at a lower cost may also consider the iHear MatriX.

The Signia Pure C&G IX is a premium prescription behind-the-ear hearing aid released in 2023, currently available at $3,298. In HearAdvisor's lab testing, it earned an A grade with a SoundScore of 4.1/5, ranking #20 among 36 prescription hearing aids tested. This device demonstrates consistent strength across multiple performance areas. Speech in quiet scored a solid 4.0/5, sitting 0.65 points above the category average. Speech in noise performance, while above the category average by 0.25 points, remains mixed in absolute terms at 2.2/5—a common challenge across prescription devices. Feedback handling is a standout feature, achieving a perfect 5.0/5 and exceeding the already-high category average. Own-voice comfort scores a solid 3.2/5, running 0.45 points above the category average, which suggests good occlusion management. Music streaming performs solidly at 3.0/5, also above average for the category by 0.36 points. The device supports both iPhone and Android streaming along with hands-free functionality. Professional tuning yields meaningful improvement, with the normalized score increasing from 4.0/5 to 4.5/5. Buyers seeking top-tier performance in this price range should note that competitors like the Phonak Sphere Infinio (5.0/5) and Oticon Intent (4.85/5) scored higher in our testing. The Pure C&G IX may suit those who prioritize reliable feedback control and balanced everyday performance over maximum speech-in-noise capability.